e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reversing concepts on COPD irreversibility
Soriano J. B., Mannino D. M.
Source:
Eur Respir J 2008; 31: 695-696
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Soriano J. B., Mannino D. M.. Reversing concepts on COPD irreversibility. Eur Respir J 2008; 31: 695-696
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology
Source: ERS Satellites 2021
Year: 2021
Rethinking COPD Exacerbations: a global patient perspective
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021
Clinical implications of the new concepts regarding COPD pathophysiology
Source: Annual Congress 2008 - New insights into COPD pathophysiology
Year: 2008
Translating mechanisms to new drugs for COPD exacerbations
Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD”
Year: 2009
Dissecting COPD exacerbations: time to rethink our definition
Source: Eur Respir J, 50 (3) 1701432; 10.1183/13993003.01432-2017
Year: 2017
Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Accelerated ageing in COPD
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018
AATD: Implications for our understanding of usual COPD
Source: Annual Congress 2013 –Alpha-1 antitrypsin deficiency and the lung: celebrating the 50th anniversary of its first description
Year: 2013
Defining “stable chronic hypercapnia” in patients with COPD: the physiological perspective
Source: Eur Respir J, 55 (2) 1902172; 10.1183/13993003.02172-2019
Year: 2020
Defining “stable chronic hypercapnia” in patients with COPD: the physiological perspective
Source: Eur Respir J, 55 (2) 1902365; 10.1183/13993003.02365-2019
Year: 2020
Challenges in COPD exacerbations and future research and unknowns
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013
Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities
Source: Eur Respir J 2014; 43: 662-664
Year: 2014
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018
Possible mechanisms underlying the development of cachexia in COPD
Source: Eur Respir J 2008; 31: 492-501
Year: 2008
Are COPD and cardiovascular disease fundamentally intertwined?
Source: Eur Respir J 2016; 47:1307-1309
Year: 2016
Some aspects of COPD ethiopathogenesis
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Reversibility at pulmonary function tests: can it have implications in patients with COPD?
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept